Printer Friendly

Printed from http://www.researchandmarkets.com/reports/2060450

Gliosarcoma Global Clinical Trials Review, H1, 2012

Description:
Gliosarcoma Global Clinical Trials Review, H1, 2012

Summary

GlobalData's clinical trial report, “Gliosarcoma Global Clinical Trials Review, H1, 2012" provides data on the Gliosarcoma clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Gliosarcoma. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Gliosarcoma. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Keywords

Gliosarcoma Clinical Trials, Trial Designs, Subjects Recruited, Unaccomplished Trials of Gliosarcoma , Pfizer, AstraZeneca, Novartis, GlaxoSmithKline, Sanofi, Eli Lilly and Company, Johnson & Johnson, Merck & Co., Inc, Bristol-Myers Squibb Company, Abbott Laboratories, Hoffmann-La Roche Ltd., Celgene Corporation, Daiichi Sankyo Company, Ltd., Bayer AG, Eisai Inc., GE Healthcare, Biogen Idec Inc., Copharos Inc., Wyeth Pharmaceuticals Inc., National Cancer Center, The University of Texas, M.D. Andersons, Vanderbilt Medical Center, Memorial Sloan Kettering Cancer Center, Cancer Research UK, North Central Cancer Group, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Fred Hutchinson Cancer Research Center, European Organization for Research and Treatment of Cancer, Dana-Farber Cancer Institute, The Cancer and Leukemia Group B, Columbia University, UCLA's Jonsson Comprehensive Cancer Center, Case Comprehensive Cancer Center, Mayo Clinic, Duke University, Ohio State University, National Cancer Center, University of Pennsylvania.
 
Contents:


List of Tables
List of Figures
Introduction
Gliosarcoma
Report Guidance
Clinical Trials by Region
Clinical Trials by Country
Top Countries Contributing to Clinical Trials in Asia-Pacific
Top Countries Contributing to Clinical Trials in Europe
Top Countries Contributing to Clinical Trials in North America
Clinical Trials by BRIC Nations
Clinical Trials by G7 Nations
Clinical Trials in G7 Nations by Trial Status
Clinical Trials by E7 Nations
Clinical Trials in E7 Nations by Trial Status
Clinical Trials by Phase
In Progress Trials by Phase
Clinical Trials by Trial Status
Unaccomplished Trials of Gliosarcoma
Subjects Recruited Over a Period of Time
Prominent Sponsors
Top Companies Participating in Gliosarcoma Therapeutics Clinical Trials
Prominent Drug Comparison
Clinical Trial Profiles
Clinical Trial Overview of Top Companies
Arno Therapeutics, Inc.
Clinical Trial Overview of Arno Therapeutics, Inc.
Celldex Therapeutics, Inc.
Clinical Trial Overview of Celldex Therapeutics, Inc.
Exelixis, Inc.
Clinical Trial Overview of Exelixis, Inc.
Merck & Co., Inc.
Clinical Trial Overview of Merck & Co., Inc.
Biogen Idec Inc.
Clinical Trial Overview of Biogen Idec Inc.
Clinical Trial Overview of Top Universities / Institutes / Hospitals
Duke University
Clinical Trial Overview of Duke University
City of Hope National Medical Center
Clinical Trial Overview of City of Hope National Medical Center
Dana-Farber Cancer Institute
Clinical Trial Overview of Dana-Farber Cancer Institute
Fred Hutchinson Cancer Research Center
Clinical Trial Overview of Fred Hutchinson Cancer Research Center
Wake Forest University
Clinical Trial Overview of Wake Forest University
Neurological Surgery, P.C.
Clinical Trial Overview of Neurological Surgery, P.C.
Center for Neurosciences
Clinical Trial Overview of Center for Neurosciences
Alberta Health Services
Clinical Trial Overview of Alberta Health Services
Memorial Sloan Kettering Cancer Center
Clinical Trial Overview of Memorial Sloan Kettering Cancer Center
University of California, Los Angeles
Clinical Trial Overview of University of California, Los Angeles
Radiation Therapy Oncology Group
Clinical Trial Overview of Radiation Therapy Oncology Group
Case Comprehensive Cancer Center
Clinical Trial Overview of Case Comprehensive Cancer Center
Roswell Park Cancer Institute
Clinical Trial Overview of Roswell Park Cancer Institute
Hopitaux Universitaires de Geneve
Clinical Trial Overview of Hopitaux Universitaires de Geneve
University of California, San Francisco
Clinical Trial Overview of University of California, San Francisco
The University of Texas M. D. Anderson Cancer Center
Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center
Five Key Clinical Profiles
Appendix
Abbreviations
Definitions
Research Methodology
Secondary Research
About GlobalData
Contact Us
Disclaimer
Source

List of Tables
Gliosarcoma Therapeutics Market, Global, Clinical Trials by Zone, 2012-
Gliosarcoma Therapeutics Market, Global, Clinical Trials by Top Countries, 2012-
Gliosarcoma Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012-
Gliosarcoma Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2012-
Gliosarcoma Therapeutics Clinical Trials, Europe, Top Countries, 2012-
Gliosarcoma Therapeutics Clinical Trials, North America, Top Countries, 2012-
Gliosarcoma Therapeutics Clinical Trials, BRIC Countries, 2012-
Gliosarcoma Therapeutics Clinical Trials, G7 Countries, 2012-
Gliosarcoma Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012-
Gliosarcoma Therapeutics Clinical Trials, E7 Countries, 2012-
Gliosarcoma Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012-
Gliosarcoma Therapeutics Market, Global, Clinical Trials by Phase, 2012-
Gliosarcoma Therapeutics Market, Global, Clinical Trials In Progress by Phase 2012-
Gliosarcoma Therapeutics Market, Global, Clinical Trials by Trial Status, 2012-
Gliosarcoma Therapeutics Market, Global, Suspended Clinical Trials, 2012-
Gliosarcoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010
Gliosarcoma Therapeutics Clinical Trials, Global, Key Sponsors, 2012-
Gliosarcoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012-
Gliosarcoma Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012-
Gliosarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Arno Therapeutics, Inc., 2012-
Gliosarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Celldex Therapeutics, Inc., 2012-
Gliosarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Exelixis, Inc., 2012-
Gliosarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2012-
Gliosarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Biogen Idec Inc., 2012-
Gliosarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Duke University, 2012-
Gliosarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by City of Hope National Medical Center, 2012-
Gliosarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Dana-Farber Cancer Institute, 2012-
Gliosarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Fred Hutchinson Cancer Research Center, 2012-
Gliosarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Wake Forest University, 2012-
Gliosarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Neurological Surgery, P.C., 2012-
Gliosarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Center for Neurosciences, 2012-
Gliosarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Alberta Health Services, 2012-
Gliosarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2012-
Gliosarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, Los Angeles, 2012-
Gliosarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Radiation Therapy Oncology Group, 2012-
Gliosarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Case Comprehensive Cancer Center, 2012-
Gliosarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Roswell Park Cancer Institute, 2012-
Gliosarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Hopitaux Universitaires de Geneve, 2012-
Gliosarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, San Francisco, 2012-
Gliosarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Texas M. D. Anderson Cancer Center, 2012-

List of Figures
Gliosarcoma Therapeutics Market, Global, Clinical Trials by Zone (%), 2012-
Gliosarcoma Therapeutics Market, Global, Clinical Trials by Top Countries, 2012-
Gliosarcoma Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012-
Gliosarcoma Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2012-
Gliosarcoma Therapeutics Clinical Trials, North America, Top Countries (%), 2012-
Gliosarcoma Therapeutics Clinical Trials, G7 Countries (%), 2012-
Gliosarcoma Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012-
Gliosarcoma Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012-
Gliosarcoma Therapeutics Market, Global, Clinical Trials by Phase (%), 2012-
Gliosarcoma Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2012-
Gliosarcoma Therapeutics Market, Global, Clinical Trials by Trial Status, 2012-
Gliosarcoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010
Gliosarcoma Therapeutics Clinical Trials, Global, Key Sponsors, 2012-
Gliosarcoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012-
Gliosarcoma Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012-
GlobalData Methodology
 
Ordering:
Order Online - visit http://www.researchandmarkets.com/reports/2060450

Order by Fax - using the order form below

Order By Post - print the order form below and send to

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.

 
Page 1 of 2
Printed Jul 22th 2014
4:53:03 PM

Fax order form

To place a fax order simply print this form, fill in and fax the completed form to the number below. If you have any questions please email help@researchandmarkets.net

Order information

Please verify that the product information is correct and select the format you require.

Product name

Gliosarcoma Global Clinical Trials Review, H1, 2012

Web Address

http://www.researchandmarkets.com/reports/2060450

Office Code

OC8DIMPPNQQSQT

 

Report Formats

Please enter the quantity of the report format you require.

Format Quantity Price
Electronic (PDF) - Enterprisewide USD 3,000
Electronic (PDF) - Site License USD 2,000
Electronic (PDF) - Single User USD 1,000

Contact information

Please enter all the information below in block capitals.

Title:
Mr Mrs Dr Miss Ms Prof
First Name:
Last Name:
Email Address:
Job Title:
Organisation:
Address:
City:
Postal / Zip Code:
Country:
Phone Number:
Fax Number:

Please fax this form to:
(646) 607-1907 or (646) 964-6609 (from USA)
+353-1-481-1716 or +353-1-653-1571 (from Rest of World)

Page 2 of 2
Printed Jul 22th 2014
4:53:03 PM

Payment information

Please indicate the payment method you would like to use by selecting the appropriate box.

Pay by Credit Card:

American Express

Diners Club

Master Card

Visa

Cardholder's Name:
Cardholder's Signature:
Expiry Date:
/
Card Number:
CVV Security Code:
Issue date:
/ (Diners Club only)
 
Pay by Check:

Please post the check, accompanied by this form, to:

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.

 
Pay by Wire Transfer:

Please transfer funds to:

Account Number:
83313083
Sort Code:
98-53-30
Swift Code:
ULSBIE2D
IBAN Number:
IE78ULSB98533083313083
Bank Address:
Ulster Bank,
27-35 Main Street
Blackrock,
Co. Dublin
Ireland.
 

If you have a Marketing Code please enter it below:

Marketing Code:

Please note that by ordering from Research and Markets you are agreeing to our Terms and Conditions at http://www.researchandmarkets.com/info/terms.asp

Please fax this form to:
(646) 607-1907 or (646) 964-6609 (from USA)
+353-1-481-1716 or +353-1-653-1571 (from Rest of World)